Topical Antibacterial Agents

Medical Clinics of North America

Volumn 95, Issue 4, 2011, Pages 703-721

  Lio, Peter A ^a   Kaye, Elaine T ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Antiseptics; Bacitracin; Gentamicin; Mupirocin; Neomycin; Polymyxin

Indexed keywords

ALCOHOL; ANTI ACNE AGENT; ANTIINFECTIVE AGENT; BACITRACIN; BENZOYL PEROXIDE; CHLORHEXIDINE; DAPSONE; HYDROGEN PEROXIDE; HYPOCHLORITE; IODINE; IODOPHOR; NEOMYCIN; POLYMYXIN; POVIDONE IODINE; PSEUDOMONIC ACID; RETAPAMULIN; SULFADIAZINE SILVER; TRICLOSAN; TROLEANDOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTISEPSIS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BURN; DRUG EFFICACY; HUMAN; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; PYODERMA; REVIEW; STAPHYLOCOCCUS AUREUS; TOPICAL TREATMENT; WOUND INFECTION;

EID: 79958827782     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2011.03.008     Document Type: Review

References (129)

1. Jones M.E., Karlowsky J.A., Draghi D.C., et al. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 2003, 22(4):406-419.
2. Larson E.L., Butz A.M., Gullette D.L., et al. Alcohol for surgical scrubbing?. Infect Control Hosp Epidemiol 1990, 11(3):139-143.
3. Fuursted K., Hjort A., Knudsen L. Evaluation of bactericidal activity and lag of regrowth (postantibiotic effect) of five antiseptics on nine bacterial pathogens. J Antimicrob Chemother 1997, 40(2):221-226.
4. Tatnall F.M., Leigh I.M., Gibson J.R. Comparative study of antiseptic toxicity on basal keratinocytes, transformed human keratinocytes and fibroblasts. Skin Pharmacol 1990, 3(3):157-163.
5. Pericone C.D., Park S., Imlay J.A., et al. Factors contributing to hydrogen peroxide resistance in Streptococcus pneumoniae include pyruvate oxidase (spxb) and avoidance of the toxic effects of the Fenton reaction. J Bacteriol 2003, 185(23):6815-6825.
6. Repine J.E., Fox R.B., Berger E.M. Hydrogen peroxide kills Staphylococcus aureus by reacting with staphylococcal iron to form hydroxyl radical. J Biol Chem 1981, 256(14):7094-7096.
7. Best M., Springthorpe V.S., Sattar S.A. Feasibility of a combined carrier test for disinfectants: studies with a mixture of five types of microorganisms. Am J Infect Control 1994, 22(3):152-162.
8. Lau W.Y., Wong S.H. Randomized, prospective trial of topical hydrogen peroxide in appendectomy wound infection. High risk factors. Am J Surg 1981, 142(3):393-397.
9. O'Toole E.A., Goel M., Woodley D.T. Hydrogen peroxide inhibits human keratinocyte migration. Dermatol Surg 1996, 22(6):525-529.
10. Milstone A.M., Passaretti C.L., Perl T.M. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008, 46(2):274-281.
11. Nicoletti G., Boghossian V., Gurevitch F., et al. The antimicrobial activity in vitro of chlorhexidine, a mixture of isothiazolinones ('kathon' cg) and cetyl trimethyl ammonium bromide (ctab). J Hosp Infect 1993, 23(2):87-111.
12. Hibbard J.S., Mulberry G.K., Brady A.R. A clinical study comparing the skin antisepsis and safety of chloraprep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine. J Infus Nurs 2002, 25(4):244-249.
13. Tattawasart U., Hann A.C., Maillard J.Y., et al. Cytological changes in chlorhexidine-resistant isolates of Pseudomonas stutzeri. J Antimicrob Chemother 2000, 45(2):145-152.
14. Kaul A.F., Jewett J.F. Agents and techniques for disinfection of the skin. Surg Gynecol Obstet 1981, 152(5):677-685.
15. Mermel L. Choice of disinfectants in obtaining blood cultures. Pediatr Infect Dis J 1994, 13(5):425-426.
16. Whitman T.J., Herlihy R.K., Schlett C.D., et al. Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial. Infect Control Hosp Epidemiol 2010, 12:1207-1215.
17. Sandri A.M., Dalarosa M.G., Ruschel de Alcantara L., et al. Reduction in incidence of nosocomial methicillin-resistant staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 2006, 27(2):185-187.
18. Wendt C., Schinke S., Wurttemberger M., et al. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 2007, 28(9):1036-1043.
19. Vernon M.O., Hayden M.K., Trick W.E., et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006, 166(3):306-312.
20. Levy I., Katz J., Solter E., et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. Pediatr Infect Dis J 2005, 24(8):676-679.
21. Rupp M.E., Lisco S.J., Lipsett P.A., et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005, 143(8):570-580.
22. Chlebicki M.P., Safdar N. Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2007, 35(2):595-602.
23. Heath R.J., Rubin J.R., Holland D.R., et al. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem 1999, 274(16):11110-11114.
24. Noronha C., Almeida A. Local burn treatments-topical antimicrobial agents. Ann Burn Fire Disasters 2000, 8(4):216-219.
25. Ward R.S., Saffle J.R. Topical agents in burn and wound care. Phys Ther 1995, 75(6):526-538.
26. Gocke D.J., Ponticas S., Pollack W. In vitro studies of the killing of clinical isolates by povidone-iodine solutions. J Hosp Infect 1985, 6(Suppl A):59-66.
27. Fleischer W., Reimer K. Povidone-iodine in antisepsis-state of the art. Dermatology 1997, 195(Suppl 2):3-9.
28. Niedner R. Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents. Dermatology 1997, 195(Suppl 2):89-92.
29. Kramer S.A. Effect of povidone-iodine on wound healing: a review. J Vasc Nurs 1999, 17(1):17-23.
30. Hsu S., Quan L. Topical antibacterial agents. Comprehenisve dermatologic drug therapy 2001, 472-496. WB Saunders, Phildelphia. S.E. Wolverton (Ed.).
31. Harkaway K.S., McGinley K.J., Foglia A.N., et al. Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol 1992, 126(6):586-590.
32. Gelmetti C. Local antibiotics in dermatology. Dermatol Ther 2008, 21(3):187-195.
33. Barillo D.J. Topical antimicrobials in burn wound care: a recent history. Wounds 2008, 20:192-198.
34. Huang J.T., Abrams M., Tlougan B., et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009, 123(5):e808-e814.
35. Kaplan S.L. Commentary: prevention of recurrent staphylococcal infections. Pediatr Infect Dis J 2008, 27(10):935-937.
36. Fisher R.G., Chain R.L., Hair P.S., et al. Hypochlorite killing of community-associated methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2008, 27(10):934-935.
37. Onset Dermatologics web site. Available at: Accessed April 10, 2011. http://www.onsetdermatologics.com/products/hylatopicplus-aurstat-kit.
38. Nagai K., Murata T., Ohta S., et al. Two different mechanisms are involved in the extremely high-level benzalkonium chloride resistance of a Pseudomonas fluorescens strain. Microbiol Immunol 2003, 47(10):709-715.
39. Halling H. Suspected link between exposure to hexachlorophene and malformed infants. Ann N Y Acad Sci 1979, 320:426-435.
40. Thuille N., Fille M., Nagl M. Bactericidal activity of herbal extracts. Int J Hyg Environ Health 2003, 206(3):217-221.
41. Kalemba D., Kunicka A. Antibacterial and antifungal properties of essential oils. Curr Med Chem 2003, 10(10):813-829.
42. Pappa K.A. The clinical development of mupirocin. J Am Acad Dermatol 1990, 22(5 Pt 1):873-879.
43. Spann C.T., Tutrone W.D., Weinberg J.M., et al. Topical antibacterial agents for wound care: a primer. Dermatol Surg 2003, 29(6):620-626.
44. Antonio M., McFerran N., Pallen M.J. Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46(2):438-442.
45. Jones J.C., Rogers T.J., Brookmeyer P., et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007, 45(5):541-547.
46. Walker E.S., Vasquez J.E., Dula R., et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?. Infect Control Hosp Epidemiol 2003, 24(5):342-346.
47. Koning S., van der Wouden J.C., Chosidow O., et al. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Br J Dermatol 2008, 158(5):1077-1082.
48. Woodford N., Afzal-Shah M., Warner M., et al. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin. J Antimicrob Chemother 2008, 62(4):766-768.
49. Weinberg J.M., Tyring S.K. Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureus. J Drugs Dermatol 2010, 9(10):1198-1204.
50. Wolf R., Matz H., Orion E., et al. Dapsone. Dermatol Online J 2002, 8(1).
51. Draelos Z.D., Carter E., Maloney J.M., et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol 2007, 56(3):439. e1-10.
52. Wolf R., Orni-Wasserlauf R. A century of the synthesis of dapsone: its anti-infective capacity now and then. Int J Dermatol 2000, 39(10):779-783.
53. Gette M.T., Marks J.G., Maloney M.E. Frequency of postoperative allergic contact dermatitis to topical antibiotics. Arch Dermatol 1992, 128(3):365-367.
54. Leyden J.J. The role of topical antibiotics in dermatologic practice Medscape. Available at:, Accessed November 30, 2008. http://www.medscape.com/viewprogram/2501.
55. Winkelman W., Gratton D. Topical antibacterials. Clin Dermatol 1989, 7(3):156-162.
56. Kuznar W. Allergen of the year: reactions to common antibiotic bacitracin may be on the rise. Dermatology times 2003, June 1, Available at:, Accessed November 30, 2008. http://www.modernmedicine.com/modernmedicine/article/articledetail.Jsp?Ts=1228065479155&id=60907.
57. Jacob S.E., James W.D. From road rash to top allergen in a flash: bacitracin. Dermatol Surg 2004, 30(4 Pt 1):521-524.
58. Hendley J.O., Ashe K.M. Eradication of resident bacteria of normal human skin by antimicrobial ointment. Antimicrob Agents Chemother 2003, 47(6):1988-1990.
59. Hammond B., Ali Y., Fendler E., et al. Effect of hand sanitizer use on elementary school absenteeism. Am J Infect Control 2000, 28(5):340-346.
60. Boyce J.M. Using alcohol for hand antisepsis: dispelling old myths. Infect Control Hosp Epidemiol 2000, 21(7):438-441.
61. Liu C., Bayer A., Cosgrove S.E., et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011, 52(3):e18-e55.
62. Paulson D.S., Fendler E.J., Dolan M.J., et al. A close look at alcohol gel as an antimicrobial sanitizing agent. Am J Infect Control 1999, 27(4):332-338.
63. Girou E., Loyeau S., Legrand P., et al. Efficacy of handrubbing with alcohol-based solution versus standard handwashing with antiseptic soap: randomised clinical trial. BMJ 2002, 325(7360):362.
64. Hilburn J., Hammond B.S., Fendler E.J., et al. Use of alcohol hand sanitizer as an infection control strategy in an acute care facility. Am J Infect Control 2003, 31(2):109-116.
65. White C., Kolble R., Carlson R., et al. The effect of hand hygiene on illness rate among students in university residence halls. Am J Infect Control 2003, 31(6):364-370.
66. Gruendemann B.J., Bjerke N.B. Is it time for brushless scrubbing with an alcohol-based agent?. AORN J 2001, 74(6):859-873.
67. Laupland K.B., Conly J.M. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 2003, 37(7):933-938.
68. von Eiff C., Becker K., Machka K., et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Engl J Med 2001, 344(1):11-16.
69. Bradley S.F. Effectiveness of mupirocin in the control of methicillin-resistant Staphylococcus aureus. Infect Med 1993, 10:23-31.
70. van Rijen M., Bonten M., Wenzel R., et al. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008, 4:CD006216.
71. Perl T.M., Cullen J.J., Wenzel R.P., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002, 346(24):1871-1877.
72. Bode L.G., Kluytmans J.A., Wertheim H.F., et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010, 362:9-17.
73. Mupirocin Study Group Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol 1996, 7(11):2403-2408.
74. Wertheim H.F., Vos M.C., Ott A., et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med 2004, 140(6):419-425.
75. Chambers H.F., Winston L.G. Mupirocin prophylaxis misses by a nose. Ann Intern Med 2004, 140(6):484-485.
76. Gorwitz R.J., Kruszon-Moran D., McAllister S.K., et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008, 197(9):1226-1234.
77. Datta R., Huang S.S. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 2008, 47(2):176-181.
78. Mayall B., Martin R., Keenan A.M., et al. Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward. J Hosp Infect 1996, 32(4):257-266.
79. Watanabe H., Masaki H., Asoh N., et al. Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2001, 39(10):3775-3777.
80. Patel J.B., Gorwitz R.J., Jernigan J.A. Mupirocin resistance. Clin Infect Dis 2009, 49:935-941.
81. Fung S., O'Grady S., Kennedy C., et al. The utility of polysporin ointment in the eradication of methicillin-resistant Staphylococcus aureus colonization: a pilot study. Infect Control Hosp Epidemiol 2000, 21(10):653-655.
82. Jeyaratnam D., Gottlieb A., Ajoku U., et al. Validation of the IDI-MRSA system for use on pooled nose, axilla, and groin swabs and single swabs from other screening sites. Diagn Microbiol Infect Dis 2008, 61(1):1-5.
83. Yang E.S., Tan J., Eells S., et al. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S aureus skin infections. Clin Microbiol Infect 2010, 16:425-431.
84. Simor A.E., Phillips E., McGeer A., et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007, 44(2):178-185.
85. Fung S.K., Louie M., Simor A.E. Combined topical and oral antimicrobial therapy for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonization in hospitalized patients. Can J Infect Dis 2002, 13(5):287-292.
86. Kokai-Kun J.F., Walsh S.M., Chanturiya T., et al. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother 2003, 47(5):1589-1597.
87. Caelli M., Porteous J., Carson C.F., et al. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000, 46(3):236-237.
88. McMahon M.A., Blair I.S., Moore J.E., et al. Habituation to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia) is associated with reduced susceptibility to antibiotics in human pathogens. J Antimicrob Chemother 2007, 59(1):125-127.
89. McMahon M.A., Tunney M.M., Moore J.E., et al. Changes in antibiotic susceptibility in staphylococci habituated to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia). Lett Appl Microbiol 2008, 47(4):263-268.
90. Langford J.H., Artemi P., Benrimoj S.I. Topical antimicrobial prophylaxis in minor wounds. Ann Pharmacother 1997, 31(5):559-563.
91. Maddox J.S., Ware J.C., Dillon H.C. The natural history of streptococcal skin infection: prevention with topical antibiotics. J Am Acad Dermatol 1985, 13(2 Pt 1):207-212.
92. Geronemus R.G., Mertz P.M., Eaglstein W.H. Wound healing. The effects of topical antimicrobial agents. Arch Dermatol 1979, 115(11):1311-1314.
93. Berger R.S., Pappert A.S., Van Zile P.S., et al. A newly formulated topical triple-antibiotic ointment minimizes scarring. Cutis 2000, 65(6):401-404.
94. Proposed recommended practices for surgical skin preparation. Association of operating room nurses. AORN J 1996, 63(1):221-227.
95. Gilmore O.J., Martin T.D., Fletcher B.N. Prevention of wound infection after appendicectomy. Lancet 1973, 1(7797):220-222.
96. Garibaldi R.A. Prevention of intraoperative wound contamination with chlorhexidine shower and scrub. J Hosp Infect 1988, 11(Suppl B):5-9.
97. de Jong T.E., Vierhout R.J., van Vroonhoven T.J. Povidone-iodine irrigation of the subcutaneous tissue to prevent surgical wound infections. Surg Gynecol Obstet 1982, 155(2):221-224.
98. Rogers D.M., Blouin G.S., O'Leary J.P. Povidone-iodine wound irrigation and wound sepsis. Surg Gynecol Obstet 1983, 157(5):426-430.
99. Tatnall F.M., Leigh I.M., Gibson J.R. Assay of antiseptic agents in cell culture: conditions affecting cytotoxicity. J Hosp Infect 1991, 17(4):287-296.
100. Brown C.D., Zitelli J.A. A review of topical agents for wounds and methods of wounding. Guidelines for wound management. J Dermatol Surg Oncol 1993, 19(8):732-737.
101. Leyden J.J., Kligman A.M. Rationale for topical antibiotics. Cutis 1978, 22(4):515-520. 22-8.
102. Watcher M.A., Wheeland R.G. The role of topical agents in the healing of full-thickness wounds. J Dermatol Surg Oncol 1989, 15(11):1188-1195.
103. Forbes G.B. Staphylococcal infection of operation wounds with special reference to topical antibiotic prophylaxis. Lancet 1961, 2:505.
104. Fielding G., Rao A., Davis N.C., et al. Prophylactic topical use of antibiotics in surgical wounds: a controlled clinical trial using " Polybactrin" Med J Aust 1965, 2(4):159-161.
105. Gisby J., Bryant J. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Antimicrob Agents Chemother 2000, 44(2):255-260.
106. Wahdan H.A. Causes of the antimicrobial activity of honey. Infection 1998, 26(1):26-31.
107. Moore O.A., Smith L.A., Campbell F., et al. Systematic review of the use of honey as a wound dressing. BMC Complement Altern Med 2001, 1(2).
108. Fraser J.F., Bodman J., Sturgess R., et al. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns 2004, 30(1):35-41.
109. Singer A.J., Dagum A.B. Current management of acute cutaneous wounds. N Engl J Med 2008, 359(10):1037-1046.
110. Chung J.Y., Herbert M.E. Myth: silver sulfadiazine is the best treatment for minor burns. West J Med 2001, 175(3):205-206.
111. Rode H., Hanslo D., de Wet P.M., et al. Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection. Antimicrob Agents Chemother 1989, 33(8):1358-1361.
112. Sinha R., Agarwal R.K., Agarwal M. Povidone iodine plus neosporin in superficial burns-a continuing study. Burns 1997, 23(7/8):626-628.
113. Subrahmanyam M. A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. Burns 1998, 24(2):157-161.
114. Kwakman P.H., Van den Akker J.P., Guclu A., et al. Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization. Clin Infect Dis 2008, 46(11):1677-1682.
115. Feng Q.L., Wu J., Chen G.Q., et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000, 52(4):662-668.
116. MacKeen P.C., Person S., Warner S.C., et al. Silver-coated nylon fiber as an antibacterial agent. Antimicrob Agents Chemother 1987, 31(1):93-99.
117. George A., Rubin G. A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract 2003, 53(491):480-487.
118. Mertz P.M., Marshall D.A., Eaglstein W.H., et al. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Arch Dermatol 1989, 125(8):1069-1073.
119. Rist T., Parish L.C., Capin L.R., et al. A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema. Clin Exp Dermatol 2002, 27(1):14-20.
120. O'Meara S.M., Cullum N.A., Majid M., et al. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 2001, 88(1):4-21.
121. O'Meara S., Al-Kurdi D., Ologun Y., et al. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2010, (1):CD003557.
122. Saji M., Taguchi S., Uchiyama K., et al. Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J Hosp Infect 1995, 31(3):225-228.
123. Walker J.R., Shafiq N.A., Allen R.G. Bacterial cell division regulation: physiological effects of crystal violet on Escherichia coli lon + and lon - strains. J Bacteriol 1971, 108(3):1296-1303.
124. Natarajan S., Williamson D., Grey J., et al. Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey. J Dermatolog Treat 2001, 12(1):33-36.
125. Kanj L.F., Phillips T.J. Management of leg ulcers. Fitzpatrick's J Clin Dermatol 1994, 52-60.
126. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis 2003, 37(6):764-771.
127. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002, 136(11):792-801.
128. Zinner S.H., Denny-Brown B.C., Braun P., et al. Risk of infection with intravenous indwelling catheters: effect of application of antibiotic ointment. J Infect Dis 1969, 120(5):616-619.
129. Maki D.G., Band J.D. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981, 70(3):739-744.